Tag: Covectra

  • New Leadership at Covectra

    New Leadership at Covectra

    Covectra, a track-and-trace company, has named Gary Miloscia as president and CEO. Steve Wood, co-founder and CEO since Covectra’s inception in 2008, will transition to serving on the board of directors and as a senior advisor to the management team.

    “As a leading provider of serialization, track-and-trace and authentication technologies, Covectra is poised to leverage its technology and strategic position to enhance value for its customers,” said Wood in a statement. “I have served over 14 years as CEO and have been proud and fortunate to work with an outstanding and dedicated group of employees. I am deeply grateful for their hard work and commitment and am confident Gary Miloscia will be an excellent leader for Covectra.”

    Since 2015, Miloscia has served as Covectra’s chief financial officer and chief marketing officer, responsible for its strategic business, financial planning, marketing and product development initiatives. Prior to Covectra, Miloscia held senior finance roles at Fidelity Investments, Health Dialog and American Express. Miloscia received a Bachelor of Science degree in finance from Rutgers University and a Master of Business Administration degree from Indiana University’s Kelley School of Business.

    “I am very excited for the opportunity to assume my new role at Covectra,” said Miloscia. “We have a strong business model and very talented management team that uniquely positions us in providing exceptional serialization and innovative brand protection solutions to our customers. I look forward to leading the company through its next chapter as we move forward to fully commercialize our new StellaGuard security label.”

  • Covectra Appoints New Directors

    Covectra Appoints New Directors

    Covectra, a supplier of serialization and track-and-trace solutions for tobacco and other applications, has appointed Renaat Van den Hooff and Gary Miloscia to its board of directors, effective Feb. 15, 2021.

    Van den Hooff brings more than 35 years of global operating experience in the healthcare industry, with specific expertise in consumer pharmaceuticals, medical devices and supplies/services for the pharmaceutical industry. He held various senior leadership positions as CEO and board member of Temptime Corp. and as president and CEO of a public startup healthcare company that developed and sold innovative wound care products. He had a 20-year career with Johnson & Johnson, serving the latter time there as president of the J&J-Merck consumer pharmaceuticals joint venture worldwide.

    Miloscia has more than 22 years of experience in management. He currently serves as chief financial officer for Covectra where he is responsible for all strategic business and financial planning and analysis as well as marketing activities. Prior to joining Covectra, he held senior level positions at Fidelity Investments, Health Dialog and American Express.

    “On behalf of the entire board of directors, it is a pleasure to welcome Renaat and Gary, two highly accomplished industry veterans, to our team,” said Steve Wood, president and CEO of Covectra, in a statement. “Their collective experience across a range of diverse strategic roles will be highly instrumental as we continue to advance our product development and build out our pipeline. I look forward to working with them and leveraging their unique expertise.”